MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
This Quarter Return
+3.77%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$261M
AUM Growth
+$261M
(-16%)
Cap. Flow
-$52.9M
Cap. Flow
% of AUM
-20.3%
Top 10 Holdings %
Top 10 Hldgs %
55.72%
Holding
40
New
12
Increased
7
Reduced
11
Closed
10
Top Buys
| 1 |
Cencora
COR
|
$13.9M |
| 2 |
AbbVie
ABBV
|
$13.9M |
| 3 |
Medtronic
MDT
|
$11.2M |
| 4 |
Johnson & Johnson
JNJ
|
$10.8M |
| 5 |
Perrigo
PRGO
|
$8.1M |
Top Sells
| 1 |
Alkermes
ALKS
|
$20.4M |
| 2 |
MON
Monsanto Co
MON
|
$18.4M |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
$13.1M |
| 4 |
Insulet
PODD
|
$12.8M |
| 5 |
DexCom
DXCM
|
$12M |
Sector Composition
| 1 | Healthcare | 95.86% |
| 2 | Industrials | 0% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $21.6M | 7.91% | 244,073 +77,348 | +46% | +$6.84M |
|
2
Eli Lilly
LLY
$657B
| $19.3M | 7.08% | 310,917 +42,830 | +16% | +$2.66M |
|
|
MNK
3
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $16.4M | 6.01% | 204,882 +22,916 | +13% | +$1.83M |
|
|
4
DexCom
DXCM
$29.5B
| $15.8M | 5.77% | 397,265 -301,570 | -43% | -$12M |
|
|
5
Cencora
COR
$56.5B
| $13.9M | 5.1% | +191,670 | New | +$13.9M |
|
|
6
AbbVie
ABBV
$372B
| $13.9M | 5.09% | +245,901 | New | +$13.9M |
|
7
HCA Healthcare
HCA
$94.5B
| $11.6M | 4.24% | 205,055 +11,829 | +6% | +$667K |
|
|
8
Medtronic
MDT
$119B
| $11.2M | 4.11% | +175,824 | New | +$11.2M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $10.8M | 3.97% | 69,249 -4,862 | -7% | -$760K |
|
|
10
Johnson & Johnson
JNJ
$427B
| $10.8M | 3.94% | +102,768 | New | +$10.8M |
|
11
Universal Health Services
UHS
$11.6B
| $10.7M | 3.93% | 111,887 -11,872 | -10% | -$1.14M |
|
12
Accuray
ARAY
$157M
| $9.7M | 3.56% | 1,102,494 +415,925 | +61% | +$3.66M |
|
|
ZLTQ
13
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $9.53M | 3.49% | 627,523 +41,458 | +7% | +$630K |
|
14
Encompass Health
EHC
$12.3B
| $8.55M | 3.13% | 238,359 +45,720 | +24% | +$1.64M |
|
|
15
Perrigo
PRGO
$3.27B
| $8.1M | 2.97% | +55,554 | New | +$8.1M |
|
|
ACOR
16
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $7.98M | 2.92% | +236,713 | New | +$7.98M |
|
17
Biogen
BIIB
$19.4B
| $7.93M | 2.91% | 25,161 -11,815 | -32% | -$3.73M |
|
|
MGLN
18
DELISTED
Magellan Health Services, Inc.
MGLN
| $7.92M | 2.9% | +127,180 | New | +$7.92M |
|
|
ITMN
19
DELISTED
INTERMUNE INC
ITMN
| $7.75M | 2.84% | +175,422 | New | +$7.75M |
|
|
AEGR
20
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $6.39M | 2.34% | +199,037 | New | +$6.39M |
|
|
UAM
21
DELISTED
Universal American Corp
UAM
| $5.71M | 2.09% | +686,000 | New | +$5.71M |
|
22
Zoetis
ZTS
$69.3B
| $5.58M | 2.05% | 173,034 -187,727 | -52% | -$6.06M |
|
|
AGN
23
DELISTED
ALLERGAN INC
AGN
| $5.47M | 2.01% | 32,336 -64,291 | -67% | -$10.9M |
|
24
Tandem Diabetes Care
TNDM
$845M
| $3.48M | 1.28% | 214,248 -154,015 | -42% | -$2.5M |
|
25
Orthofix Medical
OFIX
$592M
| $3.09M | 1.13% | +85,238 | New | +$3.09M |
|